Coral Gables-based Catalyst Pharmaceuticals is betting its future on a drug called Firdapse, which is used to treat a rare neurological disease called LEMS.
Coral Gables-based Catalyst Pharmaceuticals is betting its future on a drug called Firdapse, which is used to treat a rare neurological disease called LEMS. PETER ANDREW BOSCH MIAMI HERALD STAFF
Coral Gables-based Catalyst Pharmaceuticals is betting its future on a drug called Firdapse, which is used to treat a rare neurological disease called LEMS. PETER ANDREW BOSCH MIAMI HERALD STAFF